Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	spectrin binding	ANK1 ANK2 ANK3 SPTBN5	6.63e-05	34	129	4	GO:0030507
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	FOXK2 SHOX POU2F1 E4F1 ZIC1 USF3 MTF1 UBP1 ARNT2 NFAT5 ZNF574 TBX5 FOXC2	6.98e-05	560	129	13	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	FOXK2 SHOX POU2F1 E4F1 ZIC1 USF3 MTF1 UBP1 ARNT2 NFAT5 ZNF574 TBX5 FOXC2	7.77e-05	566	129	13	GO:0001216
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	ZHX3 ZNF383 FOXK2 SHOX POU2F1 E4F1 ZIC1 ZNF26 USF3 MTF1 ZNF665 UBP1 ARNT2 ZNF221 ZBTB11 NFAT5 MYRF MNT ZNF574 TBX5 FOXC2	2.75e-04	1412	129	21	GO:0000981
GeneOntologyMolecularFunction	RNA polymerase II cis-regulatory region sequence-specific DNA binding	ZNF410 ZNF383 FOXK2 POU2F1 E4F1 ZIC1 ZNF26 MTF1 ZNF665 UBP1 ARNT2 ZNF221 ZBTB11 NFAT5 HCFC1 MNT ZNF574 TBX5 FOXC2	4.00e-04	1244	129	19	GO:0000978
GeneOntologyMolecularFunction	RNA polymerase II transcription regulatory region sequence-specific DNA binding	ZNF410 ZHX3 ZNF383 FOXK2 POU2F1 E4F1 ZIC1 ZNF26 USF3 MTF1 ZNF665 UBP1 ARNT2 ZNF221 ZBTB11 NFAT5 HCFC1 MNT ZNF574 TBX5 FOXC2	4.26e-04	1459	129	21	GO:0000977
GeneOntologyMolecularFunction	cytoskeletal anchor activity	ANK1 ANK2 ANK3	4.83e-04	24	129	3	GO:0008093
GeneOntologyMolecularFunction	cis-regulatory region sequence-specific DNA binding	ZNF410 ZNF383 FOXK2 POU2F1 E4F1 ZIC1 ZNF26 MTF1 ZNF665 UBP1 ARNT2 ZNF221 ZBTB11 NFAT5 HCFC1 MNT ZNF574 TBX5 FOXC2	5.21e-04	1271	129	19	GO:0000987
GeneOntologyMolecularFunction	cytoskeletal protein binding	PDE4B GPAA1 ANK1 ANK2 ANK3 MID2 CAPN6 DYSF CEP350 SPTBN5 FARP1 MYPN MID1 MACF1 IQGAP3 HTT PHACTR1	7.18e-04	1099	129	17	GO:0008092
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.28e-06	4	129	3	IPR029423
Domain	LRRC37AB_C	LRRC37A3 LRRC37A2 LRRC37A	1.28e-06	4	129	3	PF14914
Domain	LRRC37_N	LRRC37A3 LRRC37A2 LRRC37A	1.28e-06	4	129	3	IPR032754
Domain	LRRC37	LRRC37A3 LRRC37A2 LRRC37A	1.28e-06	4	129	3	PF15779
Domain	LRRC37A/B-like	LRRC37A3 LRRC37A2 LRRC37A	1.28e-06	4	129	3	IPR015753
Domain	ZU5	ANK1 ANK2 ANK3	2.62e-05	9	129	3	SM00218
Domain	DEATH	ANK1 ANK2 ANK3 CRADD	3.37e-05	27	129	4	SM00005
Domain	ZU5	ANK1 ANK2 ANK3	3.73e-05	10	129	3	PS51145
Domain	ZU5	ANK1 ANK2 ANK3	6.77e-05	12	129	3	PF00791
Domain	ZU5_dom	ANK1 ANK2 ANK3	6.77e-05	12	129	3	IPR000906
Domain	Death	ANK1 ANK2 ANK3 CRADD	7.61e-05	33	129	4	PF00531
Domain	Death_domain	ANK1 ANK2 ANK3 CRADD	1.34e-04	38	129	4	IPR000488
Domain	DEATH_DOMAIN	ANK1 ANK2 ANK3 CRADD	1.34e-04	38	129	4	PS50017
Pathway	REACTOME_ASPARAGINE_N_LINKED_GLYCOSYLATION	UAP1 ANK1 ANK2 ANK3 SPTBN5 LMAN1 NANS ASGR1 FUT8 TRAPPC9	4.08e-05	307	95	10	M894
Pathway	REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS	ANK1 ANK2 ANK3 SPTBN5	5.30e-05	31	95	4	M877
Pubmed	A census of human transcription factors: function, expression and evolution.	ZNF410 ZHX3 FOXK2 SHOX POU2F1 E4F1 ZIC1 TSC22D1 ZNF26 USF3 MTF1 UBP1 ARNT2 NFAT5 MYRF MNT TBX5 FOXC2	1.28e-08	908	133	18	19274049
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	FOXK2 ANK3 CRADD MID2 PCDHGB1 RNF213 KMT2C TSC22D1 USF3 NADSYN1 ARRB2 SHC2 TBC1D1 FARP1 BANP LRP1 MACF1 NFAT5 TRAPPC9 PCM1 RAI1 HTT	5.32e-08	1489	133	22	28611215
Pubmed	Human ankyrins and their contribution to disease biology: An update.	ANK1 ANK2 ANK3	5.47e-08	3	133	3	33410423
Pubmed	Ankyrin-dependent Na+ channel clustering prevents neuromuscular synapse fatigue.	ANK1 ANK2 ANK3	5.47e-08	3	133	3	34289389
Pubmed	Human transcription factor protein interaction networks.	CUL2 ZHX3 ARHGAP32 FOXK2 UBAP2 POU2F1 LIN9 TAB3 KMT2C ZNF592 G3BP2 BANP PAXIP1 XRN1 UNK HELZ UQCRC2 HCFC1 MNT TRAPPC9 PCM1	1.21e-07	1429	133	21	35140242
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	USP34 ATXN2L UBAP2 RNF213 ADCY9 CEP350 FAM193A MID1 ARNT2 BANP XRN1 UNK HELZ HCFC1 PCM1	1.52e-07	733	133	15	34672954
Pubmed	Primate segmental duplication creates novel promoters for the LRRC37 gene family within the 17q21.31 inversion polymorphism region.	LRRC37A3 LRRC37A2 LRRC37A	2.18e-07	4	133	3	22419166
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	CUL2 SETX PEX1 TGFBI FREM2 MID1 XRN1 HELZ UQCRC2 ZBTB11 HCFC1 IQGAP3 PLXNB1 ZNF574	2.19e-07	650	133	14	38777146
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L ARHGAP32 UAP1 SETX UBAP2 TAB3 CEP350 TBC1D1 XRN1 HELZ MACF1 TRAPPC9 PCM1 OTOG DYRK2	1.15e-06	861	133	15	36931259
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2E KMT2C PAXIP1 HCFC1	1.42e-06	22	133	4	26886794
Pubmed	Analysis of the role of membrane polarity in polycystic kidney disease of transgenic SBM mice.	ANK1 ANK2 ANK3	1.89e-06	7	133	3	7495297
Pubmed	A human MAP kinase interactome.	ARHGAP32 SETX ANK3 CEP350 KMT2C TSC22D1 USF3 ARRB2 HELZ MACF1 BICRAL	2.89e-06	486	133	11	20936779
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	USP34 PDE4B FOXK2 SETX ANK3 PEX1 KMT2C UBP1 FARP1 MYPN CRYBG1 MACF1 NFAT5 PLXNB1 ARMC8 PHACTR1	4.19e-06	1084	133	16	11544199
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	FOXK2 SETX E4F1 LIN9 KMT2C ZNF592 UBP1 FARP1 XRN1 UNK CRYBG1 HELZ MACF1 UQCRC2 FUT8 ZBTB11 IQGAP3 ZNF574 ARMC8	4.45e-06	1497	133	19	31527615
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	ATXN2L UBAP2 MID2 DYSF CEP350 FAM193A FARP1 G3BP2 XRN1 UNK HELZ MACF1 UQCRC2	4.49e-06	724	133	13	36232890
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 LIN9 ARRB2 FAM193A LMAN1 ZNF592 XRN1 LRP1 ZBTB11 PCM1	5.13e-06	418	133	10	34709266
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	SETX ANK1 PCDHGB3 RNF213 KMT2C FREM2 ZNF592 BTD PLXNA4 TWSG1 ZBTB11 SERPINA9 RAI1	5.35e-06	736	133	13	29676528
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	FOXK2 SETX POU2F1 E4F1 LIN9 PRDM10 UBP1 BANP LRP1 CTH HCFC1 MNT ARMC8 FOXC2	5.58e-06	857	133	14	25609649
Pubmed	Cell organization, growth, and neural and cardiac development require αII-spectrin.	ANK1 ANK2 ANK3	6.43e-06	10	133	3	22159418
Pubmed	Evolutionary dynamism of the primate LRRC37 gene family.	LRRC37A3 LRRC37A2 LRRC37A	6.43e-06	10	133	3	23064749
Pubmed	The modular nature of apoptotic signaling proteins.	ANK1 ANK2 CRADD	6.43e-06	10	133	3	10442092
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ATXN2L ANK2 CPEB3 ADCY9 G3BP2 PRRT3 MACF1 PCM1 HTT	8.12e-06	347	133	9	17114649
Pubmed	Shotgun sequencing of the human transcriptome with ORF expressed sequence tags.	ARHGAP32 UBAP2 ZNF818P RNF213 ZIC1 FREM2 NADSYN1 FAM193A BTD CRYBG1 PCM1	9.62e-06	552	133	11	10737800
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	ZNF410 ZHX3 POU2F1 TSC22D1 ZNF592 MTF1 ZNF665 UBP1 ARNT2 UNK NFAT5 MNT TBX5	1.44e-05	808	133	13	20412781
Pubmed	Purification of the cellular C1 factor required for the stable recognition of the Oct-1 homeodomain by the herpes simplex virus alpha-trans-induction factor (VP16).	POU2F1 HCFC1	1.45e-05	2	133	2	8454622
Pubmed	Interdigitated residues within a small region of VP16 interact with Oct-1, HCF, and DNA.	POU2F1 HCFC1	1.45e-05	2	133	2	9199328
Pubmed	Expanding the genetic and phenotypic spectrum of TRAPPC9 and MID2-related neurodevelopmental disabilities: report of two novel mutations, 3D-modelling, and molecular docking studies.	MID2 TRAPPC9	1.45e-05	2	133	2	38467738
Pubmed	A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease.	TYR HTT	1.45e-05	2	133	2	18625748
Pubmed	2,3,7,8-tetrachlorodibenzo-p-dioxin causes alterations in lymphocyte development and thymic atrophy in hemopoietic chimeras generated from mice deficient in ARNT2.	TYR ARNT2	1.45e-05	2	133	2	12215665
Pubmed	Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes.	MYRF HTT	1.45e-05	2	133	2	25789755
Pubmed	In silico discovery and experimental validation of new protein-protein interactions.	DYSF HTT	1.45e-05	2	133	2	21280221
Pubmed	Mid1/Mid2 expression in craniofacial development and a literature review of X-linked opitz syndrome.	MID2 MID1	1.45e-05	2	133	2	26788540
Pubmed	Rai1 duplication causes physical and behavioral phenotypes in a mouse model of dup(17)(p11.2p11.2).	TYR RAI1	1.45e-05	2	133	2	17024248
Pubmed	Distinct fetal Ank-1 and Ank-2 related proteins and mRNAs in normal and nb/nb mice.	ANK1 ANK2	1.45e-05	2	133	2	8471772
Pubmed	Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).	POU2F1 UBP1	1.45e-05	2	133	2	15207707
Pubmed	The ankyrin-B C-terminal domain determines activity of ankyrin-B/G chimeras in rescue of abnormal inositol 1,4,5-trisphosphate and ryanodine receptor distribution in ankyrin-B (-/-) neonatal cardiomyocytes.	ANK2 ANK3	1.45e-05	2	133	2	11781319
Pubmed	Structural basis of diverse membrane target recognitions by ankyrins.	ANK2 ANK3	1.45e-05	2	133	2	25383926
Pubmed	HCF-dependent nuclear import of VP16.	POU2F1 HCFC1	1.45e-05	2	133	2	9889203
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	ARHGAP32 PDE4B UBAP2 ANK2 ANK3 PTPRD FARP1 G3BP2 LRP1 MACF1 PCM1 RAI1 ARMC8 PHACTR1	2.05e-05	963	133	14	28671696
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SH3TC2 ARHGAP32 RNF213 CEP350 TSC22D1 USF3 ZNF665 MACF1 FLRT2 TRAPPC9	2.13e-05	493	133	10	15368895
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	ATXN2L ZHX3 FOXK2 SETX POU2F1 LIN9 KMT2C LMAN1 G3BP2 PAXIP1 BICRAL HCFC1 MNT PCM1 RAI1	2.23e-05	1103	133	15	34189442
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 FOXK2 DYSF ADCY9 KMT2C NADSYN1 ZNF592 BANP PAXIP1 MYRF HCFC1 IQGAP3 TRAPPC9 RAI1 HTT	2.27e-05	1105	133	15	35748872
Pubmed	Allocation of paraventricular and supraoptic neurons requires Sim1 function: a role for a Sim1 downstream gene PlexinC1.	ARNT2 PLXNA4 PLXNB1	2.95e-05	16	133	3	17356169
Pubmed	The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.	FOXK2 PRDM10 HCFC1	2.95e-05	16	133	3	20805357
Pubmed	βIV Spectrinopathies Cause Profound Intellectual Disability, Congenital Hypotonia, and Motor Axonal Neuropathy.	ANK1 ANK3	4.34e-05	3	133	2	29861105
Pubmed	A hierarchy of ankyrin-spectrin complexes clusters sodium channels at nodes of Ranvier.	ANK1 ANK3	4.34e-05	3	133	2	25362473
Pubmed	The ammonium transporter RhBG: requirement of a tyrosine-based signal and ankyrin-G for basolateral targeting and membrane anchorage in polarized kidney epithelial cells.	ANK2 ANK3	4.34e-05	3	133	2	15611082
Pubmed	Asparagine and aspartate hydroxylation of the cytoskeletal ankyrin family is catalyzed by factor-inhibiting hypoxia-inducible factor.	ANK1 ANK2	4.34e-05	3	133	2	21177872
Pubmed	Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP.	POU2F1 HCFC1	4.34e-05	3	133	2	10629049
Pubmed	Ankyrin facilitates intracellular trafficking of alpha1-Na+-K+-ATPase in polarized cells.	ANK1 ANK3	4.34e-05	3	133	2	18768923
Pubmed	Postmortem genetic analysis of sudden unexplained death syndrome under 50 years of age: A next-generation sequencing study.	ANK2 TBX5	4.34e-05	3	133	2	27005929
Pubmed	miR-449a promotes liver cancer cell apoptosis by downregulation of Calpain 6 and POU2F1.	CAPN6 POU2F1	4.34e-05	3	133	2	26375440
Pubmed	MAP kinase pathway-dependent phosphorylation of the L1-CAM ankyrin binding site regulates neuronal growth.	ANK1 ANK2	4.34e-05	3	133	2	16597699
Pubmed	CPEB3-dependent increase in GluA2 subunits impairs excitatory transmission onto inhibitory interneurons in a mouse model of fragile X.	CPEB3 TYR	4.34e-05	3	133	2	35675768
Pubmed	MID1 and MID2 homo- and heterodimerise to tether the rapamycin-sensitive PP2A regulatory subunit, alpha 4, to microtubules: implications for the clinical variability of X-linked Opitz GBBB syndrome and other developmental disorders.	MID2 MID1	4.34e-05	3	133	2	11806752
Pubmed	Binding of an ankyrin-1 isoform to obscurin suggests a molecular link between the sarcoplasmic reticulum and myofibrils in striated muscles.	ANK1 ANK2	4.34e-05	3	133	2	12527750
Pubmed	MLL5, a histone modifying enzyme, regulates androgen receptor activity in prostate cancer cells by recruiting co-regulators, HCF1 and SET1.	KMT2E HCFC1	4.34e-05	3	133	2	33050986
Pubmed	Ankyrin-Tiam1 interaction promotes Rac1 signaling and metastatic breast tumor cell invasion and migration.	ANK1 ANK3	4.34e-05	3	133	2	10893266
Pubmed	SMAR1, a novel, alternatively spliced gene product, binds the Scaffold/Matrix-associated region at the T cell receptor beta locus.	BANP FOXC2	4.34e-05	3	133	2	10950932
Pubmed	A novel p53 regulator, C16ORF72/TAPR1, buffers against telomerase inhibition.	CA11 ZNF410 UBAP2 CCN6 FREM2 NANS HELZ MAP3K15 RAI1	4.46e-05	431	133	9	33660365
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	CUL2 FOXK2 UBAP2 GPAA1 ANK3 COMT LMAN1 NANS TBC1D1 CRNN HELZ UQCRC2 IQGAP3 TRAPPC9 ARMC8 DYRK2	4.72e-05	1321	133	16	27173435
Pubmed	Long-term potentiation modulates synaptic phosphorylation networks and reshapes the structure of the postsynaptic interactome.	ARHGAP32 PDE4B ANK2 ANK3 FARP1 LRP1 MACF1	5.39e-05	251	133	7	27507650
Pubmed	Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.	FOXK2 KMT2C PAXIP1	5.94e-05	20	133	3	29785026
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	USP34 ATXN2L UBAP2 GPAA1 COMT METAP1D KMT2E TSC22D1 LMAN1 LRP1 TWSG1 FUT8 HCFC1 MNT ZNF574	5.97e-05	1203	133	15	29180619
Pubmed	Global landscape of HIV-human protein complexes.	CUL2 COMT RNF213 ARRB2 LMAN1 G3BP2 FUT8 NFAT5 ALPP	6.98e-05	457	133	9	22190034
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	ARHGAP32 ANK3 TAB3 FAM193A XRN1 HELZ MACF1	7.22e-05	263	133	7	34702444
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	ATXN2L CPEB3 FAM193A G3BP2 XRN1 UNK HELZ PCM1 DYRK2	7.59e-05	462	133	9	31138677
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CEP350 FAM193A ZNF592 XRN1 LRP1 PCM1	7.94e-05	184	133	6	32908313
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	USP34 ARHGAP32 CAPN6 DYSF ZIC1 FAM193A FARP1 ALPP	8.23e-05	363	133	8	14691545
Pubmed	Ciliogenesis is regulated by a huntingtin-HAP1-PCM1 pathway and is altered in Huntington disease.	PCM1 HTT	8.67e-05	4	133	2	21985783
Pubmed	Investigation of rare variants in LRP1, KPNA1, ALS2CL and ZNF480 genes in schizophrenia patients reflects genetic heterogeneity of the disease.	ALS2CL LRP1	8.67e-05	4	133	2	23425335
Pubmed	Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1).	KMT2E HCFC1	8.67e-05	4	133	2	23629655
Pubmed	In-silico QTL mapping of postpubertal mammary ductal development in the mouse uncovers potential human breast cancer risk loci.	PLXNA4 TBX5	8.67e-05	4	133	2	25552398
Pubmed	Physical localization of the mesoderm development (mesd) functional region.	TYR ARNT2	8.67e-05	4	133	2	10995574
Pubmed	Common variations in 4p locus are related to male completed suicide.	TBC1D1 HTT	8.67e-05	4	133	2	19115052
Pubmed	Ankyrin-R regulates fast-spiking interneuron excitability through perineuronal nets and Kv3.1b K+ channels.	ANK1 ANK3	8.67e-05	4	133	2	34180393
Pubmed	MID1, mutated in Opitz syndrome, encodes an ubiquitin ligase that targets phosphatase 2A for degradation.	MID2 MID1	8.67e-05	4	133	2	11685209
Pubmed	Physical localization of the mouse aryl hydrocarbon receptor nuclear translocator-2 (Arnt2) gene within the c112K deletion.	TYR ARNT2	8.67e-05	4	133	2	9722945
Pubmed	Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II.	KMT2C PAXIP1	8.67e-05	4	133	2	19703992
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 ATXN2L SETX OTUD5 BANP UNK HELZ MACF1 PCM1 ZNF574	9.29e-05	588	133	10	38580884
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	ZHX3 FOXK2 POU2F1 E4F1 KMT2C MTF1 ARNT2 MACF1 NFAT5 MNT FOXC2	9.31e-05	709	133	11	22988430
Pubmed	Functional proteomics mapping of a human signaling pathway.	ANK3 E4F1 EPG5 ARRB2 ZNF592 TBC1D1 PAXIP1 LRP1 MACF1 ZBTB11	9.69e-05	591	133	10	15231748
Pubmed	A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling.	CUL2 USP34 FOXK2 PTPRU PTPRD LMAN1 XRN1 LRP1 HELZ UQCRC2 FUT8 PCM1 ARMC8	9.73e-05	974	133	13	28675297
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 PEX1 RNF213 ADCY9 ZNF592 XRN1 LRP1 CRNN HELZ MACF1 BICRAL PCM1 RAI1 ZNF574	1.00e-04	1116	133	14	31753913
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATXN2L ARHGAP32 UBAP2 ANK2 ANK3 TAB3 FARP1 G3BP2 XRN1 HELZ MACF1 UQCRC2 PCM1 PHACTR1	1.24e-04	1139	133	14	36417873
Pubmed	Glial ankyrins facilitate paranodal axoglial junction assembly.	ANK2 ANK3	1.44e-04	5	133	2	25362471
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK2 ANK3	1.44e-04	5	133	2	19109891
Pubmed	CK2-regulated schwannomin-interacting protein IQCJ-SCHIP-1 association with AnkG contributes to the maintenance of the axon initial segment.	ANK2 ANK3	1.44e-04	5	133	2	25950943
Pubmed	ZNF804a regulates expression of the schizophrenia-associated genes PRSS16, COMT, PDE4B, and DRD2.	PDE4B COMT	1.44e-04	5	133	2	22384243
Pubmed	Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex.	MID1 HTT	1.44e-04	5	133	2	23443539
Pubmed	A PTIP-PA1 subcomplex promotes transcription for IgH class switching independently from the associated MLL3/MLL4 methyltransferase complex.	KMT2C PAXIP1	1.44e-04	5	133	2	26744420
Pubmed	Replication of a genome-wide case-control study of esophageal squamous cell carcinoma.	SLC9A9 EPG5 DNAH8	1.50e-04	27	133	3	18649358
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	CEP350 FAM193A MYPN UNK MACF1 PCM1	1.59e-04	209	133	6	36779422
Pubmed	Rebalancing gene haploinsufficiency in vivo by targeting chromatin.	ALS2CL KMT2C TBX5	1.67e-04	28	133	3	27256596
Pubmed	Genome wide association study (GWAS) of Chagas cardiomyopathy in Trypanosoma cruzi seropositive subjects.	SLC9A9 DYSF PTPRD MYPN PHACTR1	1.71e-04	134	133	5	24324551
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	ATXN2L OTUD5 POU2F1 KMT2C PRDM10 FAM193A MTF1 UBP1 PAXIP1 XRN1 HELZ MNT PCM1 HTT ZNF574	1.76e-04	1327	133	15	32694731
Pubmed	DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage.	FOXK2 LRRC37A2 RNF213 FAM187A	1.91e-04	74	133	4	16625196
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	USP34 SETX UBAP2 ADCY9 KMT2C ZNF592 UNK PLXNB1 RAI1	2.09e-04	529	133	9	14621295
Pubmed	Genome-wide association study identifies GPC5 as a novel genetic locus protective against sudden cardiac arrest.	LIN9 ZNF592	2.16e-04	6	133	2	20360844
Pubmed	Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence.	COMT ARRB2	2.16e-04	6	133	2	20478633
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF410 ZHX3 ZNF383 E4F1 ZIC1 PRDM10 ZNF26 ZNF592 ZNF665 ZNF221 ZBTB11 ZNF574	2.50e-04	718	91	12	28
GeneFamily	BEN domain containing	BEND2 BANP	8.82e-04	9	91	2	422
GeneFamily	Plexins	PLXNA4 PLXNB1	8.82e-04	9	91	2	683
GeneFamily	Fibronectin type III domain containing	MID2 PTPRU PTPRD MID1 FLRT2	1.29e-03	160	91	5	555
GeneFamily	UPF1 like RNA helicases	SETX HELZ	1.34e-03	11	91	2	1169
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	ZHX3 SLC9A9 UBAP2 CEP350 KMT2C PRDM10 MACF1 NFAT5 HCFC1 PCM1	2.96e-08	180	133	10	M8239
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	CUL2 USP34 ZHX3 FOXK2 SETX CRADD ADCY9 CEP350 FAM193A MID1 ARNT2 HELZ MACF1 BICRAL FLRT2 FUT8 ZBTB11 MNT	3.50e-07	856	133	18	M4500
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	ALS2CL PRDM10 PTPRD HMCN1 PAXIP1 MACF1 NFAT5	2.29e-05	166	133	7	M6826
Coexpression	HAN_SATB1_TARGETS_DN	SH3TC2 PDE4B CRADD CAPN6 DYSF TGFBI TSC22D1 ZNF26 FUT8 PCM1	3.02e-05	388	133	10	M15491
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PDE4B ANK3 CAPN6 PEX1 DNAAF9 LIN9 ADCY9 TSC22D1 FAM193A LMAN1 KLHL30 XRN1 HELZ FLRT2 MYRF PLXNB1 HTT	4.41e-05	1102	133	17	M2369
Coexpression	ONKEN_UVEAL_MELANOMA_UP	ZNF410 ZHX3 GPAA1 ANK2 COMT ADCY9 AMZ2 TSC22D1 FAM193A NANS TBC1D1 LRP1 MACF1 PHACTR1	5.08e-05	790	133	14	M12490
Coexpression	GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN	PDE4B ANK3 CAPN6 PEX1 DNAAF9 LIN9 ADCY9 TSC22D1 FAM193A LMAN1 KLHL30 XRN1 HELZ FLRT2 MYRF PLXNB1 HTT	5.64e-05	1124	133	17	MM1070
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	USP34 ATXN2L PDE4B SETX OTUD5 RNF213 KMT2E EPG5 CEP350 KMT2C ARRB2 TBC1D1 G3BP2 XRN1 CRYBG1 HELZ MACF1 NFAT5 PCM1 DYRK2	6.46e-05	1492	133	20	M40023
Coexpression	WANG_CLIM2_TARGETS_UP	CA11 ZHX3 OTUD5 LRRC37A2 NADSYN1 ARRB2 LMAN1 BANP	7.38e-05	270	133	8	M10334
Coexpression	GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN	CUL2 COMT POU2F1 BTD LRP1 UQCRC2 HTT	7.49e-05	200	133	7	M5204
Coexpression	GSE17721_CTRL_VS_POLYIC_4H_BMDC_DN	PDE4B DHX58 TSC22D1 G3BP2 MID1 XRN1 UNK	7.49e-05	200	133	7	M3714
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SETX RNF213 KMT2E CEP350 KMT2C XRN1 HELZ MACF1 PCM1	5.05e-10	200	133	10	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1\|TCGA-Pancreas / Sample_Type by Project: Shred V9	USP34 SETX LIN9 CEP350 PRDM10 HMCN1 ZNF221 NFAT5	9.25e-08	186	133	8	03db813598b67b1e08f759758a1c2023396921fa
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 ADCY9 PTPRD PLXNA4 LRP1 TBX5	1.05e-07	189	133	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	USP34 ARHGAP32 ANK3 LRRC37A3 CPEB3 KMT2C FUT8 TRAPPC9	1.55e-07	199	133	8	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 MACF1 TBX5	1.61e-07	200	133	8	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LA-03._Atrial_Cardiomyocyte\|World / Chamber and Cluster_Paper	ANK2 ANK3 DYSF TSC22D1 TBC1D1 MYPN TBX5	1.59e-06	188	133	7	6d249fe92d51a19da19ec14bb2262d394255d577
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	USP34 RNF213 EPG5 KMT2C MACF1 ZBTB11 NFAT5	1.59e-06	188	133	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.76e-06	191	133	7	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.83e-06	192	133	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.83e-06	192	133	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.83e-06	192	133	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 CRADD DNAAF9 PTPRD FARP1 MACF1 TRAPPC9	1.83e-06	192	133	7	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.83e-06	192	133	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.89e-06	193	133	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.96e-06	194	133	7	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.96e-06	194	133	7	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	1.96e-06	194	133	7	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	severe-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 ANK3 RNF213 KMT2C XRN1 MACF1 PCM1	2.17e-06	197	133	7	57ebd552f10d6278623b52a3d484d4b91ae1d028
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 EMILIN1 PTPRD LRP1 MACF1 TBX5	2.32e-06	199	133	7	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 PTPRD PLXNA4 LRP1 MACF1 TBX5	2.39e-06	200	133	7	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	droplet-Heart-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COMT TGFBI HMCN1 LRP1 TWSG1 FOXC2	1.19e-05	169	133	6	2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c
ToppCell	droplet-Heart-nan-18m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CA11 COMT TGFBI LRP1 TWSG1 FOXC2	1.40e-05	174	133	6	cf4e0567f2a4ebe5534046b1c091af59b55bdc4f
ToppCell	Basal_cells-Cryobiopsy_01\|World / lung cells shred on cell class, cell subclass, sample id	CA11 LRRC37A2 METAP1D PRDM10 HMCN1 TDRD6	1.40e-05	174	133	6	a0060be3940043015dcc49a5157de5541aed24a1
ToppCell	droplet-Heart-nan-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 CEP350 HMCN1 XRN1 MACF1 PCM1	1.50e-05	176	133	6	749b47eac5436fa34e0d243ffbc6f1897f4e431e
ToppCell	droplet-Liver-LIVER_NPC-30m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZHX3 ARHGAP32 MID2 PLXNA4 DNAH8 HCFC1	1.65e-05	179	133	6	025d414ec88d5680d99c8173e70ee3bb0b694f74
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	USP34 ANK3 RNF213 CRYBG1 MACF1 FUT8	1.75e-05	181	133	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C\|PND07-28-samps / Age Group, Lineage, Cell class and subclass	ANK2 TGFBI HMCN1 PLXNA4 PRXL2C TBX5	1.98e-05	185	133	6	427176ad9ab8d9511200fb0a132cfd1e835fe35c
ToppCell	tumor_Lymph_Node_/_Brain-Fibroblasts-Undetermined\|Fibroblasts / Location, Cell class and cell subclass	E4F1 KMT2E PTPRD HCFC1 TBX5 PHACTR1	2.04e-05	186	133	6	403ac98f72a42721f84fbd7826f251a88ae534a2
ToppCell	-Unknown-Endothelial-Myofibroblast\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 CRADD HMCN1 ARNT2 PAXIP1 XRN1	2.17e-05	188	133	6	6468fa95ad0395395301115286f2d8c0df5d3882
ToppCell	-Unknown-Endothelial\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 CRADD HMCN1 ARNT2 PAXIP1 XRN1	2.17e-05	188	133	6	7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCell	-Unknown\| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 CRADD HMCN1 ARNT2 PAXIP1 XRN1	2.17e-05	188	133	6	9cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC9A9 ANK2 EMILIN1 PTPRD PLXNA4 LRP1	2.24e-05	189	133	6	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LA-03._Atrial_Cardiomyocyte\|LA / Chamber and Cluster_Paper	ANK2 ANK3 DYSF MYPN TBX5 PHACTR1	2.37e-05	191	133	6	5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9
ToppCell	RV-08._Macrophage\|World / Chamber and Cluster_Paper	SLC9A9 PDE4B RNF213 DNAAF9 TGFBI ARRB2	2.44e-05	192	133	6	a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	ANK3 RNF213 KMT2C CRYBG1 MACF1 PCM1	2.44e-05	192	133	6	47646d7e4990be85072987f92bf18d52f8da752e
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 EMILIN1 PTPRD MID1 PLXNA4 LRP1	2.44e-05	192	133	6	df1545670370fb1010c567cd059c2783eab315f7
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 EMILIN1 PTPRD PLXNA4 LRP1 TBX5	2.44e-05	192	133	6	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 ANK2 ANK3 PTPRD SERPINA9 PHACTR1	2.59e-05	194	133	6	ba529c051f248d29f4222f4bc9801ba233859093
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	EMILIN1 PTPRD FARP1 ARNT2 MACF1 TBX5	2.59e-05	194	133	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	SLC9A9 PDE4B DYSF TGFBI ARRB2 LRP1	2.67e-05	195	133	6	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CAPN6 EMILIN1 TSC22D1 PTPRD MACF1 TBX5	2.74e-05	196	133	6	028a06ed92f1c058dcbeacd335625bf529e87a7b
ToppCell	COVID-19_Severe-PLT_0\|World / Disease Group and Platelet Clusters	GPAA1 ANK1 COMT EMILIN1 G3BP2 MACF1	2.90e-05	198	133	6	d508d69d8de233573aee14f17dd8ef054654aa54
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ANK3 LRRC37A3 ADCY9 PTPRD TRAPPC9	2.90e-05	198	133	6	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	ANK2 EMILIN1 PTPRD HMCN1 PLXNA4 TBX5	2.90e-05	198	133	6	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l34\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	UAP1 PDE4B EMILIN1 TSC22D1 FARP1 FOXC2	2.90e-05	198	133	6	3575620db5aeaeb0bdcd7a8ff65c43abd3fa13e4
ToppCell	Parenchymal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGAP32 ANK3 ADCY9 FREM2 FARP1 PHACTR1	2.99e-05	199	133	6	5cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 PTPRD LRP1 MACF1 TBX5	2.99e-05	199	133	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	Neuron\|World / Primary Cells by Cluster	ANK2 ANK3 TSC22D1 PTPRD PLXNA4 FLRT2	2.99e-05	199	133	6	1f8104fd92f04690b41d9d07ac08dc59d76bb97d
ToppCell	Neuron-Postmitotic\|World / Primary Cells by Cluster	ANK2 ANK3 TSC22D1 PTPRD PLXNA4 FLRT2	2.99e-05	199	133	6	1973527f8a7d4c6490d75c0d0ea153688166a08b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ANK2 ANK3 TSC22D1 PTPRD PLXNA4 FLRT2	2.99e-05	199	133	6	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 SETX RNF213 KMT2C HMCN1 MACF1	3.07e-05	200	133	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	PDE4B DHX58 RNF213 XRN1 MACF1 CTH	3.07e-05	200	133	6	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC9A9 ANK2 HMCN1 LRP1 FLRT2 TBX5	3.07e-05	200	133	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC9A9 ANK2 HMCN1 LRP1 FLRT2 TBX5	3.07e-05	200	133	6	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 PTPRD LRP1 MACF1 TBX5	3.07e-05	200	133	6	44a68bacdb3d5bf563bd35952176995850933a81
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SLC9A9 ANK2 HMCN1 LRP1 FLRT2 TBX5	3.07e-05	200	133	6	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC9A9 ANK2 PTPRD LRP1 MACF1 TBX5	3.07e-05	200	133	6	dc61016c61729f69649cfb21f6264e685ce83dea
ToppCell	AT1-AT2_cells-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	CA11 PTPRU MYRF PLXNB1 ALPP	7.49e-05	145	133	5	cd5de30fd948024e3ad043c9411ce9f2722178b2
ToppCell	10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8\|bone_marrow / Manually curated celltypes from each tissue	ANK3 RNF213 KMT2C CRYBG1 MACF1	1.06e-04	156	133	5	1545169694f686d28648a68b552c2ae606599d66
ToppCell	AT1-AT2_cells-IPF_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 CAPN6 ALS2CL ARNT2 MYRF	1.26e-04	162	133	5	57d627259d27f39885bf416d74bcb6656db6e27b
ToppCell	10x5'-blood-Lymphocytic_T_CD4-T_CD4/CD8\|blood / Manually curated celltypes from each tissue	USP34 ANK3 LRRC37A CRYBG1 MACF1	1.26e-04	162	133	5	b4535bcb3f469bc139e73f1122f4070013e5a1de
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CAPN6 ALS2CL TGFBI ZNF665 FOXC2	1.37e-04	165	133	5	15fd9d21dccfa80656a6fa3b72286a6a9252d403
ToppCell	10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor\|lymph-node_spleen / Manually curated celltypes from each tissue	ARL9 EMILIN1 TSC22D1 PLXNB1 FOXC2	1.37e-04	165	133	5	7b992843bd8ef92a7a76b1d681fa84efde6f5bdd
ToppCell	356C-Fibroblasts-Fibroblast-D\|356C / Donor, Lineage, Cell class and subclass (all cells)	SH3TC2 LRRC37A3 BEND2 SHC2 MID1	1.41e-04	166	133	5	7286a37b2827f3747469ffd0d76cbe81116db7ee
ToppCell	356C-Fibroblasts-Fibroblast-D-\|356C / Donor, Lineage, Cell class and subclass (all cells)	SH3TC2 LRRC37A3 BEND2 SHC2 MID1	1.41e-04	166	133	5	7c2eee0a4f45795a956acf936b85bdb35f1b1624
ToppCell	NS-critical-d_0-4-Epithelial-unknown_epithelial\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	METAP1D ALS2CL SPTBN5 BICRAL MYRF	1.41e-04	166	133	5	dd02bbe4af609c6348dc92417254f4740f2900a8
ToppCell	343B-Myeloid-Dendritic-cDC_proliferating_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	PRTN3 ANK2 HMCN1 PAXIP1 IQGAP3	1.45e-04	167	133	5	3461d14e36f09ddc6ee5549ca4797e16d3f37fcc
ToppCell	5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgG_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RNF213 BEND2 LMAN1 XRN1 FUT8	1.49e-04	168	133	5	f5a18123f84c62211d9279e9c41e90122e4c4895
ToppCell	wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	CAPN6 TSC22D1 FARP1 FLRT2 TBX5	1.67e-04	172	133	5	415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0
ToppCell	AT1-AT2_cells-HP_01\|World / lung cells shred on cell class, cell subclass, sample id	ANK2 CAPN6 ALS2CL ARNT2 MYRF	1.81e-04	175	133	5	9a95ab5c361ebaa8747983c5a0d69025682a19ad
ToppCell	3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho\|lymph-node_spleen / Manually curated celltypes from each tissue	SI DNAAF9 LRP1 TWSG1 DNAH8	1.91e-04	177	133	5	53040dbeb18574a48e352e4bce252c7c3018762c
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGAP32 ANK3 MACF1 MNT RAI1	2.01e-04	179	133	5	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	EMILIN1 TGFBI PLXNA4 LRP1 TBX5	2.01e-04	179	133	5	02c90d8306016365ed811f0c63cfb3ac7b85464c
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ADCY9 FREM2 CRYBG1 MAP3K15	2.11e-04	181	133	5	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	ZHX3 ANK2 CPEB3 ARNT2 MAP3K15	2.17e-04	182	133	5	041bc819e6cf2618bf86bce8dfe2df673f392ba3
ToppCell	Calu_3-infected\|Calu_3 / Cell line, Condition and Strain	RNF213 CEP350 KMT2C XRN1 NFAT5	2.22e-04	183	133	5	8f7f5000645f24f20a8d7700c4df1f8953a1780b
ToppCell	10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	EPG5 MTF1 UQCRC2 ZBTB11 RAI1	2.22e-04	183	133	5	f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 FREM2 PTPRD HMCN1 OTOG	2.28e-04	184	133	5	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SETX CEP350 XRN1 MACF1 PCM1	2.28e-04	184	133	5	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 FREM2 PTPRD HMCN1 OTOG	2.28e-04	184	133	5	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 FREM2 PTPRD HMCN1 OTOG	2.28e-04	184	133	5	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	ALS2CL FARP1 MID1 MYRF PHACTR1	2.34e-04	185	133	5	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	EMILIN1 HMCN1 LRP1 FLRT2 FOXC2	2.34e-04	185	133	5	c85bba1210f1d389add3e40be9b96abac40cf8c1
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 TGFBI PLXNA4 LRP1 TBX5	2.34e-04	185	133	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	PDE4B PCDHGB3 SHOX TSC22D1 UNK	2.34e-04	185	133	5	d42dcc92a34fcdabf112565fbd5fd26cbd4de58a
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP32 DYSF TGFBI PTPRD TDRD6	2.40e-04	186	133	5	f73cb91e74a806858650ae97f543fc779ba4cff8
ToppCell	3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PDE4B TGFBI ARRB2 ASGR1 PHACTR1	2.40e-04	186	133	5	0859737021747518731aa67fe181d4ca4fdc0721
ToppCell	10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ARHGAP32 DYSF TGFBI PTPRD TDRD6	2.40e-04	186	133	5	8694ca16c9780729f4fba67ba20e35745f1eb4e9
ToppCell	metastatic_Lymph_Node-Fibroblasts-COL13A1+_matrix_FBs\|metastatic_Lymph_Node / Location, Cell class and cell subclass	ANK2 EMILIN1 HMCN1 FLRT2 TBX5	2.46e-04	187	133	5	e04fb35f2f5b120659d06b5ae427ab1ec56d5c36
ToppCell	human_hepatoblastoma-Tumor_cells-T2\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CRADD DNAAF9 ASGR1 FARP1 MID1	2.46e-04	187	133	5	f3e37c18ac6471c7992609bbddfa4975571c815c
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK3 FREM2 PLXNA4 FLRT2 TBX5	2.52e-04	188	133	5	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-naive_T_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRTN3 EMILIN1 LMAN1 FUT8 PCM1	2.52e-04	188	133	5	e079a3873cf442e98ff41a240c80b80995aace11
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 MID1 CRYBG1 MAP3K15 NFAT5	2.52e-04	188	133	5	e30a4ddac0da8cdcf621d98e28e3895cd9307e7a
ToppCell	(2)_Fibroblasts-(20)_Fibro-1\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	ANK2 TGFBI HMCN1 LRP1 FLRT2	2.52e-04	188	133	5	409a7b69d02e87084ca955e3fe6c77230dee8861
ToppCell	facs-Marrow-KLS-3m-Hematologic-hematopoietic_stem_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 PRTN3 EMILIN1 TSC22D1 FUT8	2.58e-04	189	133	5	533685a921a65d84107d8d33c43b4fffde019143
ToppCell	facs-Heart-LA/RA-3m\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ANK3 KLHL30 MYPN TBX5	2.58e-04	189	133	5	a08b2d0fa35ffa510050ecffdc68e1b79bbe1632
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 ADCY9 MID1 CRYBG1 TWSG1	2.58e-04	189	133	5	fc88c51ace7d883c01617f3f9b5fab70cc91cc09
ToppCell	facs-Marrow-KLS-3m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGAP32 PRTN3 EMILIN1 TSC22D1 FUT8	2.58e-04	189	133	5	dca56ab02bf0505f9a352ff907edaef30906d854
ToppCell	facs-Heart-LA/RA\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ANK1 ANK3 KLHL30 MYPN TBX5	2.58e-04	189	133	5	efa913d9c16fc32166b484d92b6449e8a0c59e03
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	TSC22D1 PTPRD LRP1 MACF1 TBX5	2.58e-04	189	133	5	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; HL60; HT_HG-U133A	ATXN2L PDE4B UBAP2 POU2F1 CEP350 MTF1 ZBTB11 NFAT5 HCFC1 PHACTR1	7.87e-08	174	133	10	1302_UP
Disease	Manic	PDE4B ANK3 COMT ZNF592 DNAH8	2.42e-05	78	129	5	C0338831
Disease	Malignant neoplasm of breast	ANK1 ANK2 COMT LRRC37A2 POU2F1 HEPACAM2 DYSF ALS2CL EPG5 LRRC37A PTPRD FARP1 G3BP2 MACF1 PLXNB1	7.36e-05	1074	129	15	C0006142
Disease	Intellectual Disability	KMT2E KMT2C MTF1 MACF1 FUT8 ZBTB11 RAI1 HTT PHACTR1	1.60e-04	447	129	9	C3714756
Disease	diastolic blood pressure, systolic blood pressure	ANK2 ANK3 KMT2E CEP350 TBC1D1 FARP1 FAM222B LRP1 NFAT5 TRAPPC9 PCM1	1.80e-04	670	129	11	EFO_0006335, EFO_0006336
Disease	Headache	RNF213 LRP1 MACF1 PHACTR1	1.81e-04	64	129	4	HP_0002315
Disease	migraine without aura	LRP1 PHACTR1	1.88e-04	5	129	2	MONDO_0100431
Disease	Manic Disorder	PDE4B ANK3 COMT ZNF592	2.70e-04	71	129	4	C0024713
Disease	Opitz GBBB syndrome (implicated_via_orthology)	MID2 MID1	2.81e-04	6	129	2	DOID:0080697 (implicated_via_orthology)
Disease	pulse pressure measurement	USP34 ANK2 CRADD RNF213 DYSF FAM193A PTPRD MTF1 MYPN LRP1 NFAT5 HCFC1 TRAPPC9 PCM1 TBX5 PHACTR1	3.87e-04	1392	129	16	EFO_0005763
Disease	Common Migraine	LRP1 PHACTR1	3.93e-04	7	129	2	C0338480
Disease	Depression, Bipolar	PDE4B ANK3 COMT ZNF592	4.07e-04	79	129	4	C0005587
Disease	pulse pressure measurement, migraine without aura, susceptibility to, 4	LRP1 PHACTR1	6.69e-04	9	129	2	EFO_0005763, MONDO_0011847
Disease	Moyamoya disease	RNF213 LRP1 MYRF	7.17e-04	40	129	3	MONDO_0016820
Disease	Neurodevelopmental Disorders	ANK2 KMT2E KMT2C PLXNB1	7.54e-04	93	129	4	C1535926
Disease	alpha fetoprotein measurement	USP34 SETX UNK SERPINA9	9.89e-04	100	129	4	EFO_0010583
Disease	Autistic Disorder	SLC9A9 PDE4B COMT KMT2E MTF1 BTD	1.04e-03	261	129	6	C0004352
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L PDE4B ADCY9 LRP1 MACF1 NFAT5 HTT	1.13e-03	364	129	7	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	Mitral valve prolapse, response to surgery	ZNF592 TBX5	1.22e-03	12	129	2	EFO_0009951, HP_0001634
Disease	heart failure	PDE4B DYSF ZNF592 NFAT5 PHACTR1	1.35e-03	185	129	5	EFO_0003144
Disease	body fat percentage	ATXN2L PDE4B METAP1D ADCY9 LRP1 MACF1 NFAT5 HTT	1.41e-03	488	129	8	EFO_0007800
Disease	pallidum volume change measurement	ADCY9 TRAPPC9	1.43e-03	13	129	2	EFO_0021494
Disease	anti-neutrophil antibody associated vasculitis	PRTN3 TSC22D1 SERPINA9	1.54e-03	52	129	3	EFO_0004826
Disease	Yu-Zhi constitution type	FREM2 ZNF665	1.92e-03	15	129	2	EFO_0007638
Disease	third ventricle volume measurement	ANK3 PTPRD	1.92e-03	15	129	2	EFO_0010335
Disease	QRS duration	USP34 PTPRD HMCN1 BTD MYRF TBX5	2.03e-03	298	129	6	EFO_0005055
Disease	5-oxoproline measurement	GPAA1 DNAH8	2.19e-03	16	129	2	EFO_0010988
Disease	migraine without aura, susceptibility to, 4	LRP1 PHACTR1	2.19e-03	16	129	2	MONDO_0011847
Disease	QT interval	ATXN2L SLC9A9 PDE4B ZNF592 MYRF RAI1 TBX5 PHACTR1	2.46e-03	534	129	8	EFO_0004682
Disease	partial epilepsy	ADCY9 PTPRD	2.47e-03	17	129	2	EFO_0004263
Disease	cervical artery dissection	LRP1 PHACTR1	2.47e-03	17	129	2	EFO_1000059
Disease	migraine disorder, systolic blood pressure	RNF213 PHACTR1	2.77e-03	18	129	2	EFO_0006335, MONDO_0005277
Disease	diet measurement, HOMA-B	PLXNA4 NFAT5	3.09e-03	19	129	2	EFO_0004469, EFO_0008111
Disease	alcohol consumption measurement	ATXN2L ZHX3 PDE4B ZIC1 SPTBN5 FARP1 XRN1 PLXNA4 FUT8 NFAT5 HTT ZNF574 PHACTR1	3.15e-03	1242	129	13	EFO_0007878
Disease	response to COVID-19 vaccine, SARS-CoV-2 neutralizing antibody measurement	PTPRD FUT8	3.42e-03	20	129	2	EFO_0803359, EFO_0803362
Disease	Fetal Growth Retardation	COMT CTH	3.42e-03	20	129	2	C0015934
Disease	childhood trauma measurement, alcohol consumption measurement	PCDHGB3 PCDHGB1 PTPRD	3.76e-03	71	129	3	EFO_0007878, EFO_0007979
Disease	Antimigraine preparation use measurement	LRP1 PHACTR1	3.77e-03	21	129	2	EFO_0009939
Disease	vitiligo (is_implicated_in)	COMT TYR	3.77e-03	21	129	2	DOID:12306 (is_implicated_in)
Disease	testosterone measurement	ATXN2L ZHX3 PDE4B ANK2 ANK3 CRADD ADCY9 HMCN1 ASGR1 MYPN BANP MACF1 RAI1	3.93e-03	1275	129	13	EFO_0004908
Disease	blood pressure	SLC9A9 PHACTR1	4.14e-03	22	129	2	EFO_0004325
Disease	Attention Deficit Disorder	COMT PTPRD	4.14e-03	22	129	2	C0041671
Disease	Minimal Brain Dysfunction	COMT PTPRD	4.14e-03	22	129	2	C1321905
Disease	N-glycan measurement	SLC9A9 FUT8	4.14e-03	22	129	2	EFO_0004999
Disease	non-high density lipoprotein cholesterol measurement	USP34 ZHX3 COMT ASGR1 XRN1 HELZ MYRF RAI1 ZNF574	4.19e-03	713	129	9	EFO_0005689

Protein segments in the cluster

Peptide	Gene	Start	Entry
FLETVNQPHHQNVSV	TWSG1	136	Q9GZX9
QVGHLHIAQVPQGEQ	BANP	391	Q8N9N5
QNSNIQIHHYPNGIV	TGFBI	196	Q15582
GQALHQPLAHHVQQY	ALS2CL	151	Q60I27
EEQKFVQHHIGPVNT	ASGR1	196	P07306
PQGVTQQVTHKVAQH	EPG5	1096	Q9HCE0
ALQQGHENVVAHLIN	ANK1	151	P16157
SPLHQAAQQGHTDIV	ANK1	736	P16157
NRVQHSVAPTQGFHA	ARL9	41	Q6T311
QHFATQAIHVGQDPE	CTH	16	P32929
VNENTHNLQIHAGDI	AMZ2	141	Q86W34
EHQINHQGFSAEVQL	CA11	146	O75493
QVPIQFHQQRLGHGL	FAM187A	271	A6NFU0
QVVPGLVHHPQENTQ	C1orf147	51	Q96MC9
APVQNHTNKHQVFNA	FAM193A	491	P78312
HNNQINNAGFPAELH	FLRT2	71	O43155
HGEPLNVNVHVTNNS	ARRB2	211	P32121
QQLPHGFTNMAHVTQ	ATXN2L	951	Q8WWM7
EQHSHQQPGQTEVFQ	ARNT2	671	Q9HBZ2
GAQVPFRTHSLHVQQ	RAI1	161	Q7Z5J4
FQNPQTHVIENLHAA	UQCRC2	166	P22695
VQSQHSLHENGALVP	KLHL30	496	Q0D2K2
HQAAQQGHTHIINVL	ANK2	766	Q01484
PQQHQLFGHDPAVEI	PAXIP1	586	Q6ZW49
QEAQAQQQHHHLPTE	HCFC1	1701	P51610
GQAQHSHLTQATVQP	LRRC37A3	706	O60309
EQVPPSQQEQGHSVH	KMT2C	2626	Q8NEZ4
QNNVEIHVAHIQSGL	LIN9	511	Q5TKA1
GNTISHITHQNGFQV	METAP1D	231	Q6UB28
GQAQHSHLTQATVQP	LRRC37A2	706	A6NM11
GQAQHSHLTQATVQP	LRRC37A	706	A6NMS7
VLGQHVATQHFPVAE	GPAA1	446	O43292
HVASVPTAVHGQVNN	FOXK2	581	Q01167
HVFSQQQPGHIASIL	LRP1	4411	Q07954
TITQVPIHGHLLFNN	FREM2	1571	Q5SZK8
VAHGDQIVSQINHPV	BEND2	126	Q8NDZ0
VASPQVHFIMHQLNQ	PCM1	1046	Q15154
NGHFNIDNPAQNKVH	PLXNA4	786	Q9HCM2
QAQQHGISDQDTIHI	PLXNB1	1961	O43157
LHISDINDNAPVFHQ	PCDHGB1	436	Q9Y5G3
HDVDHPGVSNQFLIN	PDE4B	446	Q07343
QGLVHPQALAHQGLQ	FAM222B	206	Q8WU58
AVAHQVQIEGLINHP	DNAH8	2091	Q96JB1
PSTGLQGLQAQHQHV	KMT2E	1696	Q8IZD2
QGLQAQHQHVVNSAP	KMT2E	1701	Q8IZD2
VIIGNNGQIHYDHQN	LMAN1	166	P49257
AVGAQVVHHPQLVGQ	MNT	546	Q99583
DLNHLPGHTFAAQQQ	FOXC2	431	Q99958
QHAIQVQHIQVSGQP	PRDM10	976	Q9NQV6
HILDVNDNVPVFHQA	PCDHGB3	441	Q9Y5G1
GAHNVRTQEPTQQHF	PRTN3	86	P24158
QHHQVDLTGNQPHQA	ARHGAP32	1141	A7KAX9
QNPFVQIQNHQHAIG	HELZ	1711	P42694
QIQNHQHAIGQEPFH	HELZ	1716	P42694
HSQAQLFHPQNPIAD	NFAT5	1066	O94916
HAQIQAGTHTQTPTQ	CRNN	286	Q9UBG3
QAEIQGNINHVNVHG	IQGAP3	281	Q86VI3
FLDQHGHNLTPEEQQ	MACF1	3836	Q9UPN3
TAQAQAFLGHLHQVQ	POU2F1	41	P14859
TNAAGETQQHIQLHV	HMCN1	1901	Q96RW7
NNNIIPAHFDSVNGH	HMCN1	4296	Q96RW7
TSQHAPGQRAHVIFQ	PTPRU	76	Q92729
HTVLPSQIQHQLQYG	PHACTR1	276	Q9C0D0
PQAHLVHGVQEQTFI	ALPP	466	P05187
QVHYHNGQVFQPNPL	CCN6	126	O95389
NHVLQHAEPGNAQSV	COMT	61	P21964
QTILFNHGAVQNIAH	ARMC8	181	Q8IUR7
VSGTVQQLPAVHHVF	HTT	2176	P42858
LGIQQHHVQQGISFA	BICRAL	331	Q6AI39
FSPQIGLAQTQHHQQ	CPEB3	151	Q8NE35
HNHIGQTPAESDFQL	FARP1	201	Q9Y4F1
HQLFVGNLPHDIDEN	G3BP2	331	Q9UN86
AQHQHQGQQEPTEHP	GGT6	446	Q6P531
NHPHNVQSQVVEAFI	CRADD	151	P78560
PNQKVIHGVINSFVH	CUL2	176	Q13617
HQHVTQETQAKPGYQ	CEP350	676	Q5VT06
TFHIHAVNNQGRIVP	DNAAF9	426	Q5TEA3
KVEGTHHVNVNPNFS	DHX58	571	Q96C10
AFGINVLAANVHHPV	BTD	291	P43251
QDGSHPQEHLQILFE	ADCY9	1126	O60503
PLHQAAQQGHTHIIN	ANK3	766	Q12955
VYEVIQHIPAQQQDH	HEPACAM2	446	A8MVW5
PGVHETLNEIQHQLQ	EMILIN1	231	Q9Y6C2
QQIVHQASAGHQIIV	E4F1	676	Q66K89
QIHLFSEPQFQGHSQ	CRYBG1	1416	Q9Y4K1
PHLIVGNISNHQLTQ	CAPN6	61	Q9Y6Q1
GSHAHGQIQVQQLFE	DYRK2	81	Q92630
ALHVLQQQGLVPEHV	DYSF	1751	O75923
EHLQEAAQGPHFTQQ	PRRT3	231	Q5FWE3
QGVHIFQCVQHIQPP	PEX1	726	O43933
SAVEPINTFHGIHQN	OTUD5	306	Q96G74
INTFHGIHQNEDEPI	OTUD5	311	Q96G74
VPNKQHGQIRGYQVH	PTPRD	736	P23468
RHEPEGQSFSIQVHN	OTOG	181	Q6ZRI0
GQEAQPHQQHLSLQL	MAP3K15	1166	Q6ZN16
GQNAHNQIAIYAHQP	FUT8	501	Q9BYC5
HNNGLPDHISAQLQN	TDRD6	2006	O60522
SQHNINPHQGNAILE	SLC9A9	111	Q8IVB4
SPQHQVQPSQLGHIF	TAB3	306	Q8N5C8
TNNHLDPFGHIILNS	TBX5	161	Q99593
TQFAANHQEFLPHPQ	MTF1	476	Q14872
GFPVVHQDLSHIQQP	SETX	2576	Q7Z333
QVQAQLQLEGVAHAH	SHOX	211	O15266
QHPCFIIAEIGQNHQ	NANS	16	Q9NR45
PHLAVASVQQHGIQS	SH3TC2	686	Q8TF17
NGLPQFVQDLHDHGQ	SI	406	P14410
QQNVVINGNAHPHHL	TSC22D1	206	Q15714
NLTHTPESAIHQGFQ	SERPINA9	101	Q86WD7
LAASGHPQAQHIVEQ	SPTBN5	1586	Q9NRC6
QHQQPDDSNNIAVHV	CNBD1	101	Q8NA66
HIENQLGVSFQSHLP	ZNF665	136	Q9H7R5
GVQHVNFTNRPSVIH	PRXL2C	211	Q7RTV5
HLQPNINGSVDAISH	RNF213	2321	Q63HN8
SQTHHTAQQPFVNPA	UBAP2	891	Q5T6F2
TLQFHNQGTQVAHAV	ZBTB11	951	O95625
QNSQFIQHQRIHIGE	ZNF383	181	Q8NA42
DHHLQNGQPIVAAES	SHC2	556	P98077
GLEFQSHIPQHQVDS	ZNF592	1136	Q92610
NSHVPQQHFELVGVA	ZNF574	36	Q6ZN55
HHLQLGAAGSQEQEQ	ZNF410	361	Q86VK4
PNIKQNHYTVHGLQS	MID1	441	O15344
NHLISGHNIVQPTDI	TBC1D1	271	Q86TI0
QVQGSANDPIFLLHH	TYR	376	P14679
PQEISQVNQHHKSGF	XRN1	1261	Q8IZH2
QHLQALQQHVPAQGV	USF3	1436	Q68DE3
VVNVYEPQLQHHVAQ	UAP1	341	Q16222
HQINQVYRQGPTGIH	UBP1	491	Q9NZI7
LHEQAAGHASPNVVN	ZIC1	146	Q15915
LLSVGNQPFHQDTFH	ZNF221	66	Q9UK13
QLIVHQGVHTGNNPY	ZNF26	356	P17031
NHQIVHTGENFPNVL	ZNF818P	106	Q6ZRF7
TVVPFQDHQNGVHNY	TRAPPC9	1061	Q96Q05
SNNVVEHIFGPNLHI	USP34	371	Q70CQ2
LSQGPVVHKHQFNSN	USP34	831	Q70CQ2
PNIKQNHYTVHGLQS	MID2	491	Q9UJV3
HFLQQPQGHLSQSEN	UNK	586	Q9C0B0
NVQHLIQAALPGHVV	ZHX3	401	Q9H4I2
QQIGSHHISLNIDPA	NADSYN1	436	Q6IA69
NSPDIHIVQAGNLHS	MYPN	311	Q86TC9
QGLVPTDLHHTQQSQ	MYRF	221	Q9Y2G1